» Articles » PMID: 22234167

The Unique Profile of Cord Blood Natural Killer Cells Balances Incomplete Maturation and Effective Killing Function Upon Activation

Overview
Journal Hum Immunol
Date 2012 Jan 12
PMID 22234167
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Cord blood (CB) is increasingly used as a source of stem cells for hematopoietic stem cell transplantation, and natural killer (NK) cells may be the effectors of the antileukemic response observed after CB transplantation. Here, we analyzed the phenotype and functions of CB NK cell subsets. We determined that the percentage of NK cells was higher in CB compared with peripheral blood (PB). Furthermore, there was a higher percentage of the CD56(bright) subset in CB. CB NK cells reached a late stage of differentiation, but exhibited higher expression of NKG2A and expressed fewer killer-cell immunoglobulin-like receptors, suggesting an incomplete maturation. CB NK cells highly expressed CXCR4, but did not express L-selectin, highlighting unique homing properties of CB NK cells. CB NK cells proliferated in response to interleukin-2 and degranulated in response to stimulation with tumor cells, but failed to lyse K562 cells in (51)Cr-release assay. CB NK cells exhibited a lower interferon-γ production in comparison with PB NK cells. Culture with IL-2 increased CB NK cell functions. Our study sheds light on CB NK cell properties and highlights the potential of CB as a source of NK cells for immunotherapy.

Citing Articles

Feeder-cell-free system for production of natural killer cells from cord blood hematopoietic stem and progenitor cells.

Martin Corredera M, Paillet J, Gaudeaux P, Blein T, Sadek H, Rault P Front Immunol. 2025; 16:1531736.

PMID: 40051631 PMC: 11883473. DOI: 10.3389/fimmu.2025.1531736.


Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy.

Dehghan F, Metanat Y, Askarizadeh M, Ahmadi E, Moradi V Front Cell Dev Biol. 2025; 12:1511931.

PMID: 40007761 PMC: 11850336. DOI: 10.3389/fcell.2024.1511931.


Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation.

Khanal S, Baer A, Hossain M, Colon-Moran W, Panthi S, Bhattarai N Front Immunol. 2025; 15():1519415.

PMID: 39776903 PMC: 11703831. DOI: 10.3389/fimmu.2024.1519415.


Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy.

Qiao W, Dong P, Chen H, Zhang J Cells. 2024; 13(23.

PMID: 39682724 PMC: 11640743. DOI: 10.3390/cells13231976.


Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies.

Looi C, Loo E, Lim H, Chew Y, Chin K, Cheah S Front Immunol. 2024; 15:1484535.

PMID: 39450176 PMC: 11499120. DOI: 10.3389/fimmu.2024.1484535.